PHH-1V81

N/A

Report date: 2023/12/27 20:05:21

Base Information

Drug NamePHH-1V81
Drug Alias NameRecombinant protein receptor binding domain (RBD) fusion homodimer of XBB.1.16(HIPRA)PHH-1V81
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHipra Scientific SLU
China Registration ClassN/A

Develop Information

Active CompaniesHipra Scientific SLU
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A